US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
AbstractThe report covers forecast and analysis for the global anti-snoring treatment market. The study provides historic data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Million). In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other sources have also been considered to arrive at the indicated market numbers. Snoring is a common disorder caused due to result of repetitive narrowing and collapsing of upper airway. Snoring not only disrupts the sleeping pattern but also weakens the sleep quality of a person. Habitual snoring can be a sign of serious health problems and obstructive sleep apnea like light sleeping, interruptions in breathing, frequent waking from sleep, strain on heart, and poor night sleep. Changing lifestyle and unhealthy dietary habits like consumption of alcohol, tobacco, and smoking are some of the factors triggering the growth of anti-snoring treatment market globally. The study provides a decisive view on the anti-snoring treatment market by segmenting the market based on type, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on type the market is segmented into devices, and surgery. The devices market is further segmented into tongue stabilizing devices (TSD), mandibular advancement devices (MAD), devices, nasal devices, continuous positive airway pressure (CPAP), and other devices. The surgery segment is further divided into uvulopalatopharyngoplasty, somnoplasty, pillar procedure, tonsillectomy, radiofrequency palatoplasty, and other surgical procedures. The devices segment held major share of the market in 2018. The market for CPAP devices is likely to grow at high CAGR in the forecast period due to its growing adoption and ease in the function of airways which helps in getting sound sleep, thus escalating customer preference towards these devices. Based on end user the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. Hospitals segment held major share of the market in 2018. Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. North America held major share of the market due to new technologies being constantly developed in the market, and the diagnosis with these anti- snoring devices has proved to be more effective and helpful to patients. The study also includes drivers and restraints for the anti-snoring treatment along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the anti-snoring treatment market on global level. With the rising incidences of anatomical abnormalities of nose and throat includes tonsils, nasal polyps or deviated nasal septum results in the narrowing of the throat during sleep which has lead to high demand for anti-snoring devices. Besides, factors like growing geriatric population base, obesity, smoking and alcohol consumption, technology advancement in anti-snoring devices, and rising awareness especially in developed markets are some of the factor boosting market growth for these devices globally. The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. SAC develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players included in anti-snoring treatment market are Tomed Dr. Toussaint Gmbh, ResMed, GlaxoSmithKline, Apnea Sciences Corporation, Theravent, Sonomed, Pure Sleep Company, Meditas, Airway Management, and Fisher & Paykel Healthcare. The report segments the anti-snoring treatment market as follows: Global Anti-Snoring Treatment Market: Type Segment Analysis Device Mandibular Advancement Devices (MAD) Tongue Stabilizing Devices (TSD) Continuous Positive Airway Pressure (CPAP) Devices Nasal Devices Other Devices Surgery Uvulopalatopharyngoplasty Somnoplasty Pillar Procedure Tonsillectomy Radiofrequency Palatoplasty Other Surgical Procedures Global Anti-Snoring Treatment Market: End User Segment Analysis Hospitals Specialty Clinics Ambulatory Surgical Centers Others Global Anti-Snoring Treatment Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample Chapter 1. Preface 1.1. Report Description and Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Anti-Snoring Treatment Market, 2016-2025 (USD Million) 2.2. Anti-Snoring Treatment Market: Snapshot Chapter 3. Anti-Snoring Treatm | read more...